Posts tagged Hep C

A revolution in treatment for 3 million people in the USA chronically infected with hepatitis C is on its way

A revolution in treatment for 3 million people in the USA chronically infected with hepatitis C is on its way

$1,000 Pill For Hepatitis C Spurs Debate Over Drug Prices

$1,000 Pill For Hepatitis C Spurs Debate Over Drug Prices






AbbVie Inc. said it can win the race against Gilead Sciences to bring to market a new generation of all-oral hepatitis C drugs. 
AbbVie Inc. said it can win the race against Gilead Sciences to bring to market a new generation of all-oral hepatitis C drugs. 
Hepatitis C research is among the fastest moving industry sectors as medications hailed as game-changes just two years ago are being trumped by newer therapeutics in the pipeline. Some physicians are telling HCV patients to wait for the newer drugs, while others say patients should be treated immediately with what is already available.

Hepatitis C research is among the fastest moving industry sectors as medications hailed as game-changes just two years ago are being trumped by newer therapeutics in the pipeline. Some physicians are telling HCV patients to wait for the newer drugs, while others say patients should be treated immediately with what is already available.

Chronic disease conditions could attract pharmaceutical - ACO collaboration in diabetes, cardiovascular and Hep C, according to an atricle in the Financial Times.

Chronic disease conditions could attract pharmaceutical - ACO collaboration in diabetes, cardiovascular and Hep C, according to an atricle in the Financial Times.

AbbVie said that its new hepatitis C drug regimen has been given a breakthrough therapy designation by the Food and Drug Administration, putting it on the fast track for potential approval in the United States.

AbbVie said that its new hepatitis C drug regimen has been given a breakthrough therapy designation by the Food and Drug Administration, putting it on the fast track for potential approval in the United States.

Will we see baby boomers lining up to be tested for the liver-destroying virus hepatitis C, as the U.S. Centers for Disease Control and Prevention recommended Thursday.

Will we see baby boomers lining up to be tested for the liver-destroying virus hepatitis C, as the U.S. Centers for Disease Control and Prevention recommended Thursday.

Gilead Sciences, after paying $10.8 billion for the developer of an experimental hepatitis C drug, will soon give investors a better sense of whether its largest-deal ever is going to pay off.
Beginning next week, Gilead will release data from dozens of patients who have tried the medicine, providing the most complete evidence yet about its prospects for treating 170 million people who are infected with the virus globally.

Gilead Sciences, after paying $10.8 billion for the developer of an experimental hepatitis C drug, will soon give investors a better sense of whether its largest-deal ever is going to pay off.

Beginning next week, Gilead will release data from dozens of patients who have tried the medicine, providing the most complete evidence yet about its prospects for treating 170 million people who are infected with the virus globally.

Rival hepatitis C drugs from Merck & Co and Vertex Pharmaceuticals are effective in patients also infected with HIV, the virus that causes AIDS, according to data released on Tuesday. The Vertex drug had the more impressive results, the data showed.

Rival hepatitis C drugs from Merck & Co and Vertex Pharmaceuticals are effective in patients also infected with HIV, the virus that causes AIDS, according to data released on Tuesday. The Vertex drug had the more impressive results, the data showed.

Unfortunately, Hep C gains in notoriety. Mortality associated with hepatitis C has surpassed that of HIV, a researcher said.

Unfortunately, Hep C gains in notoriety. Mortality associated with hepatitis C has surpassed that of HIV, a researcher said.